The number of PD-L1-positive cells (including tumor cells, lymphocytes, and macrophages) compared to the total number of viable tumor cells, referred to as the CPS value, when known in the HNSCC setting, allows for a better response to immunotherapy compared to analyzing PD-L1 expression alone [166]. Here, CD274 is linked to head and neck squamous cell carcinoma.